Novavax (NVAX) Change in Inventory (2021 - 2026)

Novavax's Change in Inventory history runs 6 years deep, the most recent figure standing at $226000.0 for Q1 2026.

• In Q1 2026, Change in Inventory rose 109.52% year-over-year to $226000.0; the TTM figure through Mar 2026 stood at $5.8 million (up 281.76% YoY), while the FY2025 annual figure was $3.2 million, up 125.09% from the prior year.
• Change in Inventory was $226000.0 for Q1 2026 at Novavax, up from -$2.1 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $304.2 million in Q2 2022 to a low of -$16.8 million in Q1 2024.
• Historically, Change in Inventory has averaged $31.9 million across 5 years, with a median of $3.8 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Change in Inventory jumped 478.62% in 2022, then plunged 1236.51% in 2025.
• A 5-year view of Change in Inventory shows it stood at $51.3 million in 2022, then tumbled by 115.75% to -$8.1 million in 2023, then surged by 102.34% to $189000.0 in 2024, then tumbled by 1236.51% to -$2.1 million in 2025, then jumped by 110.52% to $226000.0 in 2026.
• The last three Change in Inventory figures came in at $226000.0 (Q1 2026), -$2.1 million (Q4 2025), and $3.8 million (Q3 2025), per Business Quant data.